[Federal Register Volume 76, Number 128 (Tuesday, July 5, 2011)]
[Notices]
[Pages 39127-39128]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-16794]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 13, 2011, Johnson 
Matthey Pharmaceutical Materials Inc., Pharmaceutical Service, 25 
Patton Road, Devens, Massachusetts 01434, made application by letter to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Remifentanil (9739) the basic class of controlled 
substance in schedule II.
    The company plans to utilize this facility to manufacture small 
quantities of the listed controlled substances in bulk and to conduct 
analytical testing in support of the company's primary manufacturing 
facility in West Deptford, New Jersey. The controlled substances 
manufactured in bulk at this facility will be distributed to the 
company's customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances,

[[Page 39128]]

may file comments or objections to the issuance of the proposed 
registration pursuant to 21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than September 6, 2011.

    Dated: June 23, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-16794 Filed 7-1-11; 8:45 am]
BILLING CODE 4410-09-P